The Bode Lab
The Bode Lab

Posters

  1. Bode L, Muhly Reinholz M, Seeger W, Rudloff S (2001) Effects of human milk oligosaccharides (HMO) on the adhesion of monocytes to endothelial cells under flow. 27th Meeting of the Federation of European Biochemical Societies, Lisbon, Portugal.  European Journal of Biochemistry 268: 221
  2. Bode L, Rudloff S (2002) Human milk oligosaccharides (HMO) inhibit monocyte adhesion to endothelial cells in a concentration dependent manner. Experimental Biology Meeting, New Orleans, Louisiana, USA.  The FASEB Journal 16: A983
  3. Bode L, Rudloff S, Kunz C, Klein N, Strobel S (2003) Human milk oligosaccharides as inhibitors of selectin mediated cell-cell interactions in the immune system. San Diego Glycobiology Symposium, San Diego, CA, USA.
  4. Bode L, Eklund EA, Murch S, Freeze HH (2003) A link between protein-losing enteropathy and loss of heparan sulfate proteoglycans. 8th Annual Conference of the Society for Glycobiology, San Diego, California, USA.  Glycobiology 13, 867
  5. Bode L, Eklund EA, Murch S, Freeze HH (2004) The loss of heparan sulfate causes protein leakage in a tissue culture model of protein-losing enteropathy. Experimental Biology Meeting, Washington, DC, USA.  The FASEB Journal 18: A944
  6. Bode L, Salvestrini C, Murch S, Park PW, Linhardt RJ, Freeze HH (2004) Proposed molecular mechanisms of protein-losing enteropathy. US/Japan Glycobiology Meeting, Honolulu , HI, USA.  Glycobiology 14: 1172
  7. Bode L, Murch S, Park PW, Freeze HH (2005) Modeling the pathomechanisms underlying protein- losing enteropathy in post-Fontan patients. Society for Glycobiology Annual Meeting, Boston, MA, USA  Glycobiology 15: 1245
  8. Bode L, DeRossi C, Eklund EA, Freeze HH (2005) The honeybee mouse – A biochemical follow-up. Society for Glycobiology Annual Meeting, Boston, MA, USA  Glycobiology 15: 1236
  9. Bode L, Murch S, Park PW, Freeze HH (2006) Modeling the pathomechanisms underlying protein- losing enteropathy. San Diego Glycobiology Symposium, San Diego, CA, USA.
  10. Bode L, Park PW, Murch S, Freeze HH (2006) Loss of cell-associated heparan sulfate (HS) amplifies IFNγ- and TNFα-induced protein leakage in a model of Protein-Losing Enteropathy (PLE). Experimental Biology Meeting, San Francisco, CA, USA. The FASEB Journal
  11. Bode L, Freeze HH (2006) Central role of heparan sulfate and heparin in pathogenesis and therapy of protein-losing enteropathy. Gordon Research Conference Proteoglycans, Andover, NH, USA.
  12. Bode L, Settergren G, Freeze HH (2006) Modeling a CDG-Ib intestine in vitro: Silencing phosphomannose isomerase predisposes for intestinal epithelial protein leakage. Society for Glycobiology Annual Meeting, Los Angeles, CA, USA.  Glycobiology 16: 1117
  13. Bode L, Linhardt RJ, Freeze HH (2006) Non-anticoagulant 2,3-de-O-sulfated heparin as a potential novel therapeutic for patients with protein-losing enteropathy. Society for Glycobiology Annual Meeting, Los Angeles, CA, USA.  Glycobiology 16: 1118-9
  14. Bode L, Freeze HH (2007) Modeling a CDG-Ib intestine: Silencing phosphomannose isomerase predisposes for intestinal epithelial protein leakage. San Diego Glycobiology Symposium, San Diego, CA, USA.
  15. Bode L, Murch S, Freeze HH (2007) The global village: Is heparan sulfate the missing link between protein-losing enteropathy and protein-energy malnutrition? Gordon Research Conference Glycobiology, Ventura, CA, USA.
  16. Bode L, Rubach M, Settergren G, Freeze H (2007) Modeling a CDG-Ib intestine: Silencing phosphomannose isomerase predisposes for intestinal protein leakage. Annual Burnham Science Network Symposium, La Jolla, CA, USA.
  17. Bode L (2007) Human milk oligosaccharides: New research perspectives. Annual Burnham Science Network Symposium, La Jolla, CA, USA.
  18. Ninonuevo MR, Nissan C, Bode L (2008) Glycomic Analysis of Membrane Proteins from Intestinal Epithelial Cells. Annual Burnham Science Network Symposium, La Jolla, CA, USA.
  19. Ninonuevo MR, Motamedchaboki K, Straubinger K, Nissan C, Bode L (2009) N-Glycome Analysis of Membrane Proteins from Intestinal Epithelial Cells. American Society for Mass Spectrometry Conference, Philadelpha, PA, USA.
  20. Nissan C, Sultana R, El-Arifeen S, Raqib R, Bode L (2010) A low body mass index reduces Human Milk Oligosaccharide concentration in breast milk of Bangladeshi women. Experimental Biology Meeting. Anaheim, CA, USA.
  21. Nissan C, Naidu N, Choudhury B, Bode L (2010) A new HPLC-based method to profile and quantify Human Milk Oligosaccharides from as little as 1 uL milk. Experimental Biology Meeting. Anaheim, CA, USA.
  22. Straubinger K, Ninonuevo M, Bode L (2010) Human milk oligosaccharides alter the intestinal epithelial cell surface glycome: A proof-of-principle. Experimental Biology Meeting, Anaheim, CA, USA.
  23. Goth K, Guner Y, Grishin A, Ford H, Bode L (2010) Human Milk Oligosaccharides Prevent Necrotizing Enterocolitis in an Animal Model. Annual Meeting, Pediatric Academic Societies. Vancouver, BC, Canada.
  24. Zherebtsov M, Jantscher-Krenn E, Nissan C, Goth K, Guner Y, Grishin A, Ford H, Bode L (2011) Human milk oligosaccharides prevent Necrotizing Enterocolitis in neonatal rats. Keystone Symposium: Mucosal Biology. Vancouver, Canada.
  25. Hunt KM, Nissan C, Bode L, McGuire MK, McGuire MA (2011) Correlations between human milk bacterial community structure and Human Milk Oligosaccharide concentration. Experimental Biology Meeting, Washington, DC.
  26. Jantscher-Krenn E, Lauwaet T, Nissan C, Bliss L, Reed SL, Gillin FD, Bode L (2011) Human Milk Oligosaccharides reduce Entamoeba histolytica adhesion and cytotoxicity in vitro. Experimental Biology Meeting, Washington, DC.
  27. Preuss J, Hedrick M, Sergienko E, Gosalia P, Milewski M, Li YL, Pinkerton A, Jortzik E, Rahlfs S, Becker K, Bode L (2012) Screening for inhibitors for Plasmodium falciparum glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase in a high-throughput format. Annual Meeting of the Society for Laboratory Automation and Screening, San Diego, CA.
  28. Preuss J, Hedrick M, Sergienko E, Pinkerton A, Jortzik E, Ralphs S, Becker K, Bode L (2012) High-throughput screening for Plasmodium falciparum glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitors. Experimental Biology Meeting, San Diego, CA.
  29. Hunt KM, Preuss J, Nissan C, Davlin C, Williams J, Richardson A, McGuire MK, Bode L, McGuire MA (2012) Human milk oligosaccharides enhance the growth of Staphylococci. Experimental Biology Meeting, San Diego, CA.
  30. Jantscher-Krenn E, Marx C, Bode L (2012) Human Milk Oligosaccharides Are Differentially Metabolized In Neonatal Rats. Experimental Biology Meeting, San Diego, CA.
  31. Marx C, Bridge R, Wolf A, Rich W, Kim JH, Bode L (2012) Human Milk Oligosaccharides In Banked Donor Milk Compared To Mother’s Milk In The NICU. Experimental Biology Meeting, San Diego, CA.
  32. Kuhn L, Kim HY, Hsiao L, Nissan C, Sinkala M, Kankasa C, Mwiya M, Thea DM, Aldrovandi GM, Bode L (2012) Human Milk Oligosaccharides and Postnatal Transmission of HIV through Breastfeeding. Experimental Biology Meeting, San Diego, CA.
  33. Chan CS, Autran C, Kim JH, Aldrovandi G, Bode L, Zambia Exclusive Breastfeeding Study Team (2012) Human Milk Galectin-3 Binding Protein (Gal3BP) Association with Maternal HIV Transmission. Annual Meeting of the Pediatric Academic Societies, Boston, MA.
  34. Autran C, Szyszka A, Bode L (2013) Milk 3’sialyllactose does not increase brain sialic acid concentration in mice. Experimental Biology Meeting, Boston, MA.
  35. Manthey CF, Autran C, Eckmann L, Bode L (2013) Human milk oligosaccharides reduce EPEC attachment in vitro and EPEC colonization in mice. Experimental Biology Meeting, Boston, MA.
  36. Williams JE, Riley MA, Hunt KM, Brooker SL, Szyszka A, Bode L, McGuire MK, McGuire MA (2013) Relationship between human milk oligosaccharides and fecal microbiome of breastfed infants. Experimental Biology Meeting, Boston, MA.
  37. Gonia S, Tuepker M, Kim JH, Bode L, Gale CA (2014) Human Milk Oligosaccharides: Prebiotic Potential for Prevention of Invasive Candidiasis. Experimental Biology Meeting, San Diego, CA.
  38. Lin A, Autran CA, Espanola SD, Lewis A, Bode L, Nizet V (2014) Human Milk Oligosaccharides Protect Bladder Epithelial Cells Against Uropathogenic E. coli and Streptococcus agalactiae Infections. Experimental Biology Meeting, San Diego, CA.
  39. Van Niekerk E, Autran CA, Nel DG, Kirsten GF, Blaauw R, Bode L (2014) Human milk oligosaccharides differ between HIV-infected and -uninfected mothers and correlate with the incidence of necrotizing enterocolitis in their preterm very low birth weight infants. 17th Conference, International Society for Research in Human Milk and Lactation, Kiawah Island, SC, USA.
  40. Lin AE, Autran CA, Escajadiolo T, Lewis AL, Doran KS, Bode L, Nizet V (2015) A Unique Human Milk Oligosaccharide Property inhibits Group B Streptococcus Growth. San Diego Glycobiology Symposium, San Diego, CA, USA.
  41. Li F, Bender J, Pannaraj P, Adisetiyo H, Santiskulvong C, Cerini C, Byrt E, Rouzier V, Martelly S, Wang S, Bode L, Fitzgerald D, Sleasman J, Kuhn L, Aldrovandi G (2015) Feeding Practices and HIV Infection Modulate Infant Gut Microbiota Maturity: A Cross-Sectional Study Across Four Geographic Sites. International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment, Bethesda, MD, USA.
  42. Bender J, Li F, Martelly S, Byrt E, Rouzier V, Pannaraj P, Adisetiyo H, Santiskulvong C, Wang S, Autran C, Bode L, Fitzgerald D, Kuhn L, Aldrovandi G (2015) Gut Microbiome and Breast Milk Oligosaccharides (GuMBO) in HIV Positive and Negative Mother Infant Pairs from Haiti. International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment, Bethesda, MD, USA.
  43. Kuhn L, Bender J, Li F, Martelly S, Byrt E, Rouzier V,  Pannaraj P, Adisetiyo H, Santiskulvong C, Wang S, Autran C, Bode L, Fitzgerald D, Aldrovandi G (2015) Perturbations in gut microbiome in infants born to HIV-infected mothers are related to maternal microbiome and human milk oligosaccharides. 8th IAS Conference on HIV Pathogenesis, Vancouver, Canada.
  44. Bertrand K, Chambers CD, Kao K, Boyle D, Kim JH, Bode L (2015) Alcohol Use Among Breastfeeding Women in the UCSD Breast Milk Biorepository Cohort. 6th Annual Pediatric Translational Faculty Research Symposium, San Diego, CA, USA.
  45. Alderete TL, Autran CA, Bode L, Brekke B, Goran MI, Fields D (2015) Associations Between Human Milk Oligosaccharides and Infant Body Composition in the First Six Months of Life. Annual meeting of The Obesity Society, Los Angeles, CA, USA.
  46. Jantscher-Krenn E, Aigner J, Zhan M, van Poppel M, Bode L, Csapo B, Desoye G (2015) First evidence of prenatal Human Milk Oligosaccharides in maternal serum. FASEB Science Research Conference, Origins and Benefits of Biologically Active Components in Human Milk, Big Sky, MT, USA.
  47. Ramani S, Laucirica D, Hu L, Bode L, Kang G, Prasad BVV, Estes MK (2015) Role of Human Milk Oligosaccharides in Neonatal Rotavirus Infections. FASEB Science Research Conference, Origins and Benefits of Biologically Active Components in Human Milk, Big Sky, MT, USA.
  48. Etzold S, Autran CA, Bode L (2015) Elucidating the mechanisms by which human milk oligosaccharides (HMO) protect against necrotizing enterocolitis (NEC). FASEB Science Research Conference, Origins and Benefits of Biologically Active Components in Human Milk, Big Sky, MT, USA.
  49. Autran CA, Szyszka A, Paulsen L, Gordts PLSM, Bode L (2015) Human Milk 3’Sialyllactose Reduces Pro-Inflammatory Cytokine Expression in Activated Macrophages. FASEB Science Research Conference, Origins and Benefits of Biologically Active Components in Human Milk, Big Sky, MT, USA.
  50. Autran CA, Schoterman MHC, Jantscher-Krenn E, Kamerling JP, Bode L (2015) Sialylated galacto-oligosaccharides and 2’-fucosyllactose reduce necrotizing enterocolitis in neonatal rats. FASEB Science Research Conference, Origins and Benefits of Biologically Active Components in Human Milk, Big Sky, MT, USA.

Dedicated to Research on Human Milk Oligosaccharides

Print Print | Sitemap
© lars bode